Sterima has been acquired by Pollet Medical Group
The shareholders of Sterima have sold the company to Pollet Medical Group. Financial details have not been disclosed.
Headquartered in Belgium, Sterima offers full service sterilization solutions for hospitals and medical devices companies in the Benelux. Additionally, the company remains the trusted provider of nursing procedure sets with reusable instruments. Sterima also producers and distributes dialysis concentrate and related medical equipment to hospitals as a subcontractor for a large customer.
Pollet Medical Group is the medical division of Pollet Group and offers medical services and solutions for the healthcare industry. Pollet Group, a family-owned business, is active in the fields of water treatment, the pool business and medical services, and has companies across Europe, the Middle East and Africa.
Malysse-Sterima is a family business active in Belgium and the Netherlands. With more than 50 years of experience, the group is the leader in services for the healthcare sector.
Oaklins’ team in Belgium acted as financial advisor to the shareholders of Sterima in this transaction.
Talk to the deal team
Related deals
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreEuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreOlyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Learn more